Skip to content
LexBuild

National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting

---
identifier: "/us/fr/E6-14556"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "E6-14556"
section_name: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting"
positive_law: false
currency: "2006-09-01"
last_updated: "2006-09-01"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E6-14556"
document_type: "notice"
publication_date: "2006-09-01"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "71 FR 52076"
fr_volume: 71
---

#  National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities (NCBDDD) announces the following meeting.

*Name:* National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE).

*Times and Dates:* September 26, 2006, 8:30 a.m.-4:30 p.m.; September 27, 2006, 8:30 a.m.-1 p.m.

*Place:* Doubletree Atlanta Buckhead, 3342 Peachtree Road, NE., Atlanta, Georgia 30326, telephone 404 231-1234, fax 404 231-3112.

*Status:* Open to the public, limited only by the space available. The meeting room accommodates approximately 80 people.

*Purpose:* The Secretary is authorized by the Public Health Service Act, Section 399G, (42 U.S.C. Section 280f, as added by Public Law 105-392) to establish a National Task Force on Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support FAS and FAE research, programs and surveillance; and (2) to otherwise meet the general needs of  populations actually or potentially impacted by FAS and FAE.

*Matters to be Discussed:* Agenda items include: Overview of recent research on innovative approaches to help in identification and diagnosis of FAS and other alcohol-related neurodevelopmental disorders, update on Task Force report of evidence-based review of fetal alcohol spectrum disorders prevention strategies; updates from the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the CDC and other Federal agencies, and liaison representatives; and scheduling of the next meeting. Agenda items are subject to change as priorities dictate.

*For Further Information Contact:* Mary Kate Weber, M.P.H., Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86), Atlanta, Georgia 30333, telephone 404 498-3926, fax 404 498-3550.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: August 28, 2006.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.